Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

D. Neil Hayes, MD, MPH, of UT/West Institute for Cancer Research has 27 manuscripts in prestigious journals in April
  • USA - English


News provided by

West Cancer Center

Apr 23, 2018, 03:00 ET

Share this article

Share toX

Share this article

Share toX

D. Neil Hayes, MD, MPH, Scientific Director of the UT/West Institute for Cancer Research
D. Neil Hayes, MD, MPH, Scientific Director of the UT/West Institute for Cancer Research

The same excitement that fueled the last generation of cancer genetics research is what I hope to bring to the team at UTHSC / West. We will offer the best of cancer research to patients, right here in the region.

Post this

Memphis, TN (PRWEB) April 23, 2018 -- After more than a decade of planning, preparation, research, and discoveries, the Cancer Genome Atlas (TCGA), the flagship effort of the National Institutes of Health, concludes its formal efforts with a flurry of nearly 27 reports in top-tier medical journals this month, including eight reports in the journal Cell. This explosion of new scientific knowledge into the genetics of over 30 different cancer types and 11,000 cancer patients concludes one of the largest team science efforts ever undertaken in the field of cancer. In addition to the final reports from TCGA issued this month, the consortium has published dozens of other high-impact reports in individual cancer types, such as lung cancer, breast cancer, and brain cancer. Through it all, including the work reported this month, D. Neil Hayes, MD, MPH, the scientific director of the UT/West Institute for Cancer Research has played one of only a handful of leadership roles.

As the principal investigator, along with collaborators Dr. Chuck Perou and Dr. Katie Hoadley of the University of North Carolina at Chapel Hill, Dr. Hayes directed one of a half-dozen centers with primary responsibility for data production and analysis. The team led by Dr. Hayes and colleagues generated data on over 11,000 patients using a revolutionary technology called “Next generation sequencing,” focusing primarily on the part of the genome called RNA, the molecule through which DNA exerts its action in cells. This new platform has made possible hundreds of new scientific discoveries in cancer reported by Dr. Hayes’ team and other colleagues involved in the TCGA, and more importantly, generated an enormous public data repository for thousands of researchers around the world. TCGA’s impact on cancer research cannot be overstated, and includes such specific impacts as redefining the way clinicians classify and treat cancer based on molecular patterns. “Dr. Hayes’ expertise in genomic analysis is further reinforced by this remarkable feat of multiple high-impact publications which dramatically enhance our understanding of cancer biology,” said Lee Schwartzberg, MD, FACP, Executive Director of West Cancer Center.

Dr. Hayes is the Van Vleet Endowed Professor in Medical Oncology in the Department of Medicine at the University of Tennessee Health Science Center (UTHSC). He holds secondary appointments in the Department of Genetics, Genomics and Informatics, and the Department of Preventive Medicine in the College of Medicine. Dr. Hayes is in his 11th year as the leader in efforts surrounding The Cancer Genome Atlas and has played a significant role not only in the recent 30 publications, but also across the dozens of reports in top journals Cell, Science, Nature and The New England Journal of Medicine. His most-cited work from the project includes efforts reported on the cover of Cancer Cell and Nature in brain cancer and aerodigestive cancer, which have been referenced thousands of times in recent years by researchers around the world.

Prior to joining West Cancer Center and UTHSC, Dr. Hayes was the co-leader of the North Carolina (UNC) Lineberger Clinical Research Program, professor in the Division of Hematology/Oncology and the Department of Otolaryngology/Head and Neck Cancer Surgery, and Director of Clinical Bioinformatics at UNC. “I stand proudly behind my record in cancer genomics, and my goal is to move genomic paradigms to clinical decision making to advance precision/personalized medicine for cancer patients in the city of Memphis, the state of Tennessee, and beyond, he said. “The same excitement that fueled the last generation of cancer genetics research is what I hope to bring to the team at UTHSC / West. We will offer the best of cancer research to patients, right here in the region” Dr. Hayes said.

# # #

About West Cancer Center
West Cancer Center is a multi-specialty, academic, regional cancer center specializing in adult cancer care and prevention. Over 37,000 patients were treated across our 12 locations in 2017 – of which, more than 13,000 were new to our network. A partnership with the University of Tennessee Health Science Center and Methodist Le Bonheur Healthcare has attracted 156 oncology specialists, researchers, and academicians; many from other leading cancer centers, now training the next generation of cancer experts. With the expansion of a new state-of-the-art campus opening in early 2019, West Cancer Center is forecasted to increase annual patient visits to 42,000 and broaden our footprint from 220,000 square feet to more than 300,000 for patient care and research. As a member of the National Comprehensive Cancer Network, West Cancer Center embraces the mission to improve quality, effectiveness, and efficiency of cancer care for all patients regardless of regional location and socioeconomic status. Our commitment to translate cancer science into revolutionary treatment protocols is furthered by the enrollment of 500 patients in clinical trials for 2017 and over 4,210 analytic cases recorded to the tumor registry annually. Focusing on genomic/drug delivery, translational targeting and new clinical pathways also provides patients with the latest, most innovative, personalized cancer treatment plans. West Cancer Center’s dedication to clinical excellence extends beyond conventional care with programs and services that focus on the mind, body, and spirit to improve overall wellness and outcomes. For more information, visit westcancercenter.org and follow us on Facebook, Twitter, YouTube and Instagram.
About the University of Tennessee/West Institute for Cancer Research
The University of Tennessee/West Institute for Cancer Research is a not-for profit public charity dedicated to raising funds for adult cancer research. Located in Memphis, TN, The UT/West Institute for Cancer Research solicits grants from government agencies, foundations and individuals to be utilized to broaden cutting-edge research programs, develop novel cancer treatments and therapeutics, and strengthen patient-focused care in all sectors of the community. Funds donated to The UT/West Institute are designated for research in four major areas of emphasis: Translational Drug Discovery and Development, Cancer Immunotherapy, Women’s Cancers and Community Outcomes. The generous philanthropy of donors and benefactors provides the necessary funding for researchers to create and produce the most effective therapies for cancer patients, with the collective goal of defeating cancer in its entirety.

Julie Flanery, West Cancer Center, http://westcancercenter.org, +1 9018008356, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.